ClearPoint Neuro, Inc. (CLPT)
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure. Among its core offerings is the ClearPoint system, designed for the precise placement of deep brain stimulation electrodes, biopsy needles, and for the controlled infusion of medications and laser catheters directly into the brain. It also provides the ClearPoint Neuro Navigation System, which is specifically engineered for MRI suite environments. ClearPoint Neuro maintains strategic partnerships and licensing agreements with prominent institutions and companies, including Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and the University of California, San Francisco. Initially established in 1998 and headquartered in Solana Beach, California, the company operated as MRI Interventions, Inc. before rebranding to ClearPoint Neuro, Inc. in February 2020.
Sector: Surgical & Medical Instruments & Apparatus
Industry: Medical - Devices
ClearPoint Neuro, Inc.
Trials need funding. See this company's dilution risk and cash position.
- Not applicableCompleted
Transesophageal Magnetic Resonance Imaging (MRI) in Conjunction With Lipid Lowering Measures
Collaborator · Lead: Johns Hopkins UniversitySimvastatin (20mg versus 80mg/day)
Heart Diseases
NCT00125060Enrollment72StartAug 2000Primary Completion-CompletionApr 2004 - ObservationalCompleted
Use of Interventional MRI for Implantation of Deep Brain Stimulator Electrodes
Collaborator · Lead: University of California, San Franciscointerventional MRI for implantation of DBS electrodes, DBS electrodes
Parkinson's Disease, Dystonia
NCT00792532Enrollment8StartJul 2003Primary CompletionMar 2019CompletionMar 2019 - Not applicableRecruiting
Deployment of Irrigating Intraventricular Catheter System for Intraventricular Hemorrhage
Collaborator · Lead: Icahn School of Medicine at Mount SinaiIRRAflow® Active Fluid Exchange System, Traditional extraventricular drain
Intraventricular Hemorrhage (IVH)
NCT05970549Enrollment17StartJun 2022Primary CompletionDec 2026est.CompletionDec 2026est.
| Drug / Therapy | Link | ||
|---|---|---|---|
| Not applicable | Completed | Simvastatin (20mg versus 80mg/day) | NCT00125060 |
| Observational | Completed | interventional MRI for implantation of DBS electrodes, DBS electrodes | NCT00792532 |
| Not applicable | Recruiting | IRRAflow® Active Fluid Exchange System, Traditional extraventricular drain | NCT05970549 |